JPRN-jRCT1071220089招募中4 期
A sub-analysis study of the prevention of atherosclerosis by SGLT2 inhibitor (a multicenter, randomized controlled study: PROTECT)
ode Koichi0 个研究点目标入组 482 人开始时间: 2023年1月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 482
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Type 2 diabetes with HbA1c (NGSP) >=6.0% and less than10.0% despite diet/exercise therapy or diet/exercise therapy adding antidiabetic agents for over three months
- •2)over 20 years of age at the time of informed consent acquisition and hospitalization or outpatient
- •3) The patient provided with information about the study,submitted written informed consent to it
排除标准
- •1) Type 1 diabetes
- •2) Has history of severe ketosis, diabetic coma, or precoma within 6 months
- •3) Has severe infection, serious trauma, or pre or post surgery (including carotid endarterectomy and stent implantation)
- •4) With severe renal dysfunction (eGRF <45 mL/min/1.73m2 or patient undergoing artificial dialysis)
- •5) Has history of myocardial infarction, angina, percutaneous transluminal coronary angioplasty, coronary artery bypass graft, cerebral infarction, intracranial hemorrhage, subarachnoid hemorrhage and transient ischemic attacks within 3 months before initiation of the study
- •6) Heart failure patient whose NYHA functional classification is III or IV
- •7) Has history of administration of SGLT-2 within 1 month before initiation of the study
- •8) Pregnant, possibly pregnant, planned to become pregnant or nursing women
- •9) Has history of hypersensitivity to ipragliflozin or any other excipient of ipragliflozin
- •10) Are considered not eligible for the study by the attending doctor due to other reasons
研究者
相似试验
招募中
1 期
Intervention of Acute Myocardial Infarction with integrated traditional Chinese Medicine and Western Medicine: a Randomized Controlled Trial.acute myocardial infarctionITMCTR2000003494Qilu Hospital of Shandong University
招募中
不适用
A Prospective Study of Prevention of Aneurysm Diameter Enlargement after Endovascular Aortic Repair of Abdominal Aortic Aneurysm by Side Branch Embolization Using Preoperative 4D Flow MRI AnalysisAbdominal Aortic AneurysmJPRN-jRCT1042210068Sano Masaki80
进行中（未招募）
1 期
Secondary Prevention of Cardiovascular Disease in the ElderlySecondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort.MedDRA version: 20.0Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 100000004849EUCTR2015-002868-17-DEFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206
进行中（未招募）
1 期
Secondary Prevention of Cardiovascular Disease in the ElderlyEUCTR2015-002868-17-CZFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206
进行中（未招募）
不适用
Secondary Prevention of Cardiovascular Disease in the ElderlySecondary Prevention of Major Cardiovascular Events (cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke, and urgent revascularization) in post MI cohort.MedDRA version: 18.1Level: LLTClassification code 10028597Term: Myocardial infarction acuteSystem Organ Class: 100000004849EUCTR2015-002868-17-ESFundación Centro Nacional de Investigaciones Cardiovasculares, Carlos III (CNIC)3,206